Impact of Milk and Yogurt Supplementation on Bone Health, Body Composition, and Gut Microbiota in Canadian Young Adults
Launched by UNIVERSITY OF SASKATCHEWAN · Feb 9, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how drinking milk and eating yogurt might affect bone health, body fat, and muscle mass in young adults in Canada. The researchers want to find out if yogurt, which contains beneficial bacteria, has a better effect on these health aspects compared to regular milk. They will be looking for participants aged 19 to 30 who don’t get enough calcium in their diet, specifically less than 1000 mg per day.
Eligible participants will be divided into three groups: one group will drink a specific amount of milk daily, another will eat a set amount of yogurt, and the third group will continue their usual diet without any changes. Over the course of 24 months, the researchers will measure various health indicators, such as bone strength and body composition. This trial aims to provide helpful information on how dairy products can support health and potentially guide future health recommendations. If you're interested and meet the criteria, this could be a great opportunity to contribute to important research!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 19-30 years old
- • Dietary calcium intake below 1000mg/ day
- • living in the Saskatoon area (Saskatchewan, Canada)
- Exclusion Criteria:
- • Calcium intake from both food and supplement above the estimated average requirement (EAR) for adults aged 19-30 years (\>800 mg/day)
- • Total dairy intake of more than 1 serving per day
- • Body mass index greater than to 30 kg/m2
- • Medical history of metabolic bone, liver, endocrine, connective tissue, and respiratory diseases, thyroid disorders, or cancer
- • Diagnosed cases with secondary osteoporosis due to hypoparathyroidism
- • Hormonal disorders or disturbances
- • Taking medications known to influence bone mass and density (e.g., steroids, diuretics, heparin, and cancer drugs)
- • Cow's milk allergy
- • Pregnant or lactating women, or those planning to conceive during the duration of the trial
About University Of Saskatchewan
The University of Saskatchewan is a leading research institution dedicated to advancing health sciences through innovative clinical trials and studies. With a commitment to improving patient outcomes, the university leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous and ethically sound research. By fostering collaborations among researchers, healthcare professionals, and industry partners, the University of Saskatchewan aims to translate scientific discoveries into practical applications that enhance healthcare delivery and contribute to the well-being of communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saskatoon, Saskatchewan, Canada
Patients applied
Trial Officials
Hassan Vatanparast, MD, PhD
Principal Investigator
University of Saskatchewan
Phil Chilibeck, PhD
Principal Investigator
University of Saskatchewan
Sandra Clarke
Principal Investigator
Agriculture and Agri-Food Canada
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported